Should every region use the same gastric cancer scanning and treatment approaches? let’s reconsider: a northeastern turkey example by unknown
RESEARCH ARTICLE Open Access
Should every region use the same
gastric cancer scanning and treatment
approaches? let’s reconsider: a
northeastern turkey example
Albayrak Fatih1, Ozturk Yasin2, Dursun Hakan2,4* and Albayrak Yavuz3
Abstract
Background: The rate for upper gastrointestinal (UGI) cancers, and especially the rate for gastric cancer, varies from
country to country and from region to region within country. In Turkey, the incidence of gastric cancer varies
widely among regions due to the diverse cultures and accompanying food habits of the population. This study
aimed to determine the endoscopic frequency of esophageal and gastric cancers and the usefulness of alarm
symptoms in diagnosing gastric cancer in subjects undergoing endoscopy in northeastern Turkey.
Methods: This retrospective study was based on hospital records, reviewing the records of patients who had
underdone esophago-gastro-duodenal (EGD) video endoscopy at two general hospitals in Erzurum. From July 2010
to January 2013, 25,037 patients from Erzurum underwent EGD procedures under either intravenous sedation or
local anesthesia. Classifications of UGI cancer, based on location of the tumor, were defined as esophageal, cardia,
cardia and fundus or corpus or all of these, corpus, corpus and antrum, and antrum. Metastasis was studied in 659
patients diagnosed with cancer.
Results: Throughout the study, 1,007 biopsy samples were reported as malignant tumors (719 gastric, 276
esophageal, and 12 duodenal cancers). The study considered the gastric cancer population under age 46, which
included 99 (13.8 %) patients. Among them, the distribution of UGI cancer by age was as follows: under age
26 years, 9 patients (0.9 %); age 26–35 years, 30 patients (3 %); and age 36–45 years, 60 patients (6 %). Overall, 298
patients (298/1007, 29.6 %) presented with localized disease, and 361 patients (35.9 %) had distant metastases at
the time of diagnosis.
Conclusions: We determined that UGI cancer patients are observed more frequently in northeastern Turkey than in
western Turkey, Europe, and the USA. We believe that alarm symptoms and endoscopic scanning programs require
new, region-specific criteria to diagnose UGI cancers in this region. For the patient groups with these different
characteristics, we believe that new scanning, follow-up, and treatment strategies are needed that take into
consideration differences in the histopathology of the tumors, their localization, and the patients’ ages.
Trial registration: There is registration number. This study is “retrospective study”. This study is “retrospectively
registered”.
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Background
Upper gastrointestinal (UGI) cancers, including esopha-
geal and gastric cancers, are among the most common
causes of cancer deaths worldwide [1]. Globally, gastric
cancer is the second most common cancer, with an esti-
mated 870,000 new cases yearly [2], and it has a poor
prognosis because in most cases it is advanced when
discovered. Early detection and treatment are among the
most important strategies for preventing and controlling
gastric cancer [3].
The rate of UGI cancer, and especially that of gastric
cancer, varies from country to country and from region
to region within countries. High-risk areas include
Eastern Europe, East Asia (China and Japan), and parts
of Central and South America. Low-risk areas include
North America, North and East Africa, Southern Asia,
Australia, and New Zealand [4]. Turkey has a relatively
high rate of gastric cancer, but its incidence varies widely
among regions due to the diverse cultures and accom-
panying food habits of the country’s population [5].
Upper UGI cancers are detected more frequently in
Erzurum province, in northeastern Turkey, than in other
regions of the country [6–9].
With a population of about 800,000, Erzurum, located
in the northeastern part of the Anatolian peninsula in
Turkey, is one of the first referral centers for neighbor-
ing cities; therefore, it serves a population of about 2.5
million, approximately 3% of Turkey’s population [10].
This study aimed to determine the endoscopic frequency
of esophageal and gastric cancers and the usefulness of
alarm symptoms for diagnosing gastric cancer in sub-
jects undergoing endoscopy in northeastern Turkey.
Methods
Setting and design
A retrospective study was carried out in the adult popula-
tion (age ≥ 18 years), reviewing the hospital records of
patients who had undergone esophago-gastro-duodenal
(EGD) video endoscopy at 2 general hospitals in Erzurum:
Ataturk University Faculty of Medicine Hospital and
Erzurum Region Research and Education Hospital, both
of which provide tertiary care and which together serve a
population of about 2.5 million. Between July 2010 and
January 2013, 25,037 patients from Erzurum underwent
EGD procedures under either intravenous sedation or
local anesthesia. The study reviewed and included all
available patient records from July 1, 2010 to January 1,
2013. The study was conducted according to the prin-
ciples of the 1975 Declaration of Helsinki and was
approved by the Ethics Committee of the Erzurum
Region Research and Education Hospital (Approval
date/number: 05.03.2013/03). The Ethics Committee of
the Erzurum Region Research and Education Hospital
does not require informed consent for retrospective
studies. Informed consent is not obtained in this study
and personal identities is not shared in this manuscript.
Classifications of UGI cancer, based on tumor location,
were defined as Eo (esophageal), GCa (cardia), GCaF and
Co (cardia and fundus or corpus or all of these), GCo
(corpus), GCoA (corpus and antrum), and GA (antrum).
The histopathology of the specimens obtained (10–12
specimens/patient) was independently determined by
senior pathologists in the 2 hospitals. Biopsies for detect-
ing Helicobacter pylori (H. pylori) were taken from the
gastric antrum for rapid urease testing or histology.
Data collection
A compilation form was designed to collect the ne-
cessary information regarding the following items: 1)
socio-demographics, including patient name/ID regis-
try, residence, gender, nationality, and age at diagnosis
of gastric cancer and 2) the health facility responsible
for referring each patients and the main presentation
at diagnosis. Then, histopathological reports were reviewed
to delineate the main cytopathological features, the subsites
affected, and the lesions’ prominent cytological characteris-
tics. After histopathological diagnosis of cancer, some cases
were excluded from follow-up because the patients were
lost due to continuing their treatments at other centers.
Therefore, metastasis could not be determined in 348 of
the 1007 cancer cases. Some patients who had undergone
endoscopy had attended another center, at which they had
also undergone H. pylori testing, so our endoscopy process
only took a biopsy from the lesion for histopathological
diagnosis. H. pylori was not present in these patients, as
determined by pathological, serological, or other methods.
Therefore, the present study did not address the informa-
tion regarding those patients who had undergone H. pylori
testing. The number of gastric cancer cases checked for the
presence of H. pylori was 512 (512/719, 71.2 %).
Data management and statistical analysis
Data management was carried out using the Statistical
Package for Social Sciences, SPSS 10 (Chicago, IL, USA).
Descriptive statistics (means, standard deviations, and
frequencies) were used to describe the studied variables.
A Chi-square test was used for cross tabulation.
Throughout analysis, the level of significance was set at
a p value < 0.05.
Results
Demography
The retrospective identified 25,037 patients who had
undergone EGD procedures. Of these, 1,007 had biopsy
samples that were reported as malignant tumors (719
gastric, 276 esophageal, and 12 duodenal cancers). The
mean age of the patients at the time of diagnosis was
63.0 ± 13.0 years (63.2 ± 13.8 for females and 62.9 ± 12.3
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for males), with the majority of patients being older than
45 years (n = 908; 90.2 %). The data revealed a general
increase in gastric tumor incidence in both genders and
in all age groups. Tables 1 and 2 show the incidence of
gastric tumors in the various age groups in females and
males, respectively. Cancers were significantly higher in
men (p < 0.05). The youngest and oldest patients with
gastric cancer were 21 and 88. There was a large pre-
dominance of newly diagnosed cases in males (n = 580;
57.6 %). In women, patients were older at diagnosis than
men (63.2 ± 13.8 vs. 62.9 ± 12.3) but no significant differ-
ence was noted between the genders (p > 0.05). The
most common patient age group at diagnosis was 56–65
years (33.7 %). Of those gastric cancer patients under
age 46, which was 99 (9.8 %) patients, the distribution
of UGI cancer within age groups was as follows: under
age 26, 9 patients (0.9 %); age 26–35, 30 patients
(3 %); and age 36–45, 60 patients (6 %). It is notable
that 9.8 % of the patients were younger than 45; of
the total of 276 patients with esophageal cancer, 15
(5.4 %) were younger than 45.
Tables 1 and 2 show the frequency of gastric cancer by
site among the various age groups in females and males,
respectively. The most common location was GCaF and
Co (n = 333; 33.1 %), followed by Eo (n = 276; 27.4 %),
GCoA (n = 135; 13.4 %), GA (n = 128; 12.7 %), GCo
(n = 123; 12.2 %), and the duodenum (n = 12; 1.2 %).
When gastric cancer cases were combined, the major-
ity (386/719; 53.7 %) were distal gastric cancers, while
a large minority of cases (n = 333, 46.3 %) were found
on proximal sites of the stomach.
Morphology
The morphology results confirmed that adenocarcin-
oma was a common gastric tumor, occurring in 630/
719 (87.6 %) patients. More than half of all tumors
(54.2 %) were caused by two main types of adenocar-
cinoma, intestinal and diffuse, and the intestinal type
Table 1 Incidence of upper gastric cancer in different age groups in males
Site
Eo GCaF and Co GCo GCoA GA D Total
Age group
Under 45 n 5 14 8 14 6 1 48
% wag 10.4 % 29.2 % 16.7 % 29.2 % 12.5 % 2.1 % 100 %
% ws 3.1 % 7.9 % 8.8 % 20.0 % 8.0 % 16.7 % 8.3 %
% T 0.9 % 2.4 % 1.4 % 2.4 % 1.0 % 0.2 % 8.3 %
46–55 n 23 22 0 24 6 1 76
% wag 30.3 % 28.9 % 0 % 31.6 % 7.9 % 1.3 % 100 %
% ws 14.4 % 12.4 % 0 % 34.3 % 8.0 % 16.7 % 13.1 %
% T 4.0 % 3.8 % 0 % 4.1 % 1.0 % 0.2 % 13.1 %
56–65 n 76 61 47 4 25 2 215
% wag 35.3 % 28.4 % 21.9 % 1.9 % 11.6 % 0.9 % 100 %
% ws 47.5 % 34.3 % 51.6 % 5.7 % 33.3 % 33.3 % 37.1 %
% T 13.1 % 10.5 % 8.1 % 0.7 % 4.3 % 03 % 37.1 %
66–75 n 41 43 33 12 17 1 147
% wag 27.9 % 29.3 % 22.4 % 8.2 % 11.6 % 0.7 % 100 %
% ws 25.6 % 24.2 32.3 % 17.1 % 22.7 % 16.7 % 25.3 %
% T 7.1 % 7.4 % 5.7 % 2.1 % 2.9 % 0.2 % 25.3 %
75 + n 15 38 3 16 21 1 94
% wag 16.0 % 4.4 % 3.2 % 17.0 % 22.3 % 1.1 % 100 %
% ws 9.4 % 21.3 % 3.3 % 22.9 % 28.0 % 16.7 % 16.2 %
% T 2.6 % 6.6 % 0.5 % 2.8 % 3.6 % 0.2 % 16.2
Total n 160 178 91 70 75 6 580
% wag 27.6 % 30.7 % 15.7 % 12.1 % 12.9 % 1.0 % 100 %
% ws 100 % 100 % 100 % 100 % 100 % 100 % 100 %
% T 27.6 % 30.7 % 15.7 % 12.1 % 12.9 % 1.0 % 100 %
Abbreviations: wag within age group, ws within site, T total, n frequency, Eo esophageal, GCaF and Co Cardia and fundus or corpus or all of them, GCo corpus,
GCoA corpus and antrum, GA antrum, D duodenum
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was common carcinoma (32.9 %). As Table 3 shows,
gastric tumors were also associated with signet ring
cell gastric cancer, occurring in 35/719 (4.9 %) pa-
tients, squamous cell carcinoma, occurring in 15/719
(2.1 %) patients, and other tumors, occurring in 39/
719 (5.4 %) patients.
Squamous cell carcinoma was a common esophageal
tumor, occurring in 207/276 (75.0 %) patients. In
addition, adenocarcinoma, occurring in 65/276 (23.6 %)
patients, and other tumors, which occurred in 4/276
(1.4 %) patients, was also associated with esophageal
tumors.
The geographic distribution was as follows: Erzurum
(n = 630, 62.6 %), Agrı (n = 180, 17.9 %), Kars (n = 78,
7.7 %), Igdır (n = 37, 3.7 %), Mus (n = 36, 3.6 %), and
other cities (Van, Ardahan, Bingöl, etc.). This distribu-
tion showed that, in addition to Erzurum, cases came
most frequently from the northeastern Anatolian region,
including Erzurum, Ağrı and Kars (Fig. 1).
Only 659 cases were checked for the presence of
metastasis. At the time of diagnosis, 298 patients (298/
1007, 29.6 %) presented with localized disease, and 361
patients (35.9 %) had distant metastases, the most
common sites for which were lymph nodes (56.1 %),
liver (30.7 %), peritonitis carcinomatosa (22.9 %), lungs
Table 2 Incidence of Upper Gastric Cancer in Different Age Groups in Females
Site
Eo GCaF and Co GCo GCoA GA D Total
Age group
Under 45 n 10 23 3 12 1 2 51
% wag 19.6 45.1 5.9 23.5 2.0 3.9 100 %
% ws 8.6 14.8 9.4 18.5 1.9 33.3 11.9 %
% T 2.3 5.4 0.7 2.8 0.2 0.5 11.9 %
46–55 n 13 15 8 6 12 1 55
% wag 23.6 27.3 14.5 10.9 21.8 1.8 100 %
% ws 11.2 9.7 25.0 9.2 22.6 16.7 12.9 %
% T 3.0 3.5 1.9 1.4 2.8 0.2 12.9 %
56–65 n 51 43 8 3 18 1 124
% wag 41.1 34.7 6.5 2.4 14.5 0.8 100 %
% ws 44.0 27.7 25.0 4.6 34.0 16.7 29.0 %
% T 11.9 10.1 1.9 0.7 4.2 0.2 29.0 %
66–75 n 32 39 12 27 10 1 121
% wag 26.4 32.2 9.9 22.3 8.3 0.8 100 %
% ws 27.6 25.2 37.5 41.5 18.9 16.7 28.3 %
% T 7.5 9.1 2.8 6.3 2.3 0.2 28.3 %
75 + n 10 35 1 17 12 1 76
% wag 13.2 46.1 1.3 22.4 15.8 1.3 100 %
% ws 8.6 22.6 3.1 26.2 22.6 16.7 17.8 %
% T 2.3 8.2 0.2 4.0 2.8 0.2 17.8 %
n 116 155 32 65 53 6 427
% wag 27.2 36.3 7.5 15.2 12.4 1.4 100 %
% ws 100 100 100 100 100 100 100 %
% T 27.2 36.3 7.5 15.2 12.4 1.4 100 %
wag with in age group, ws with in site, T total, n frequency, Eo esophageal, GCaF and Co Cardia and fundus or corpus or all of them, GCo corpus, GCoA corpus and
antrum, GA antrum, D duodenum
Table 3 Histological diagnosis of the upper gastrointestinal
cancers in patients
Site Histological type Frequency / %
Esophageal tumors Squamous cell carcinoma 207/276 / 75.0 %
Adenocarcinoma 65/276 / 23.6 %
Other tumors 4/276 / 1.4 %
Gastric tumors Adenocarcinoma 630/719 / 87.6 %
Signet ring cell 35/719 / 4.9 %
Squamous cell carcinoma 15/719 / 2.1 %
Other tumors 39/719 / 5.4 %
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(11.8 %), neck (4.8 %), and other (5.4 %) (Table 4). The
remaining patients (n = 348) had various degrees of
regional extension or an unknown stage.
In addition, 512 (512/719, 71.2 %) gastric cancer cases
were checked for the presence of H. pylori, and 329
cases (329/512, 65.2 %) were found to be positive,
according to either the rapid urease test or histology.
Discussion
Gastric cancer is the second most common cause of
death from cancer worldwide [11]. However, the overall
incidence rates for gastric cancer have steadily declined
over the past 50 years, particularly in developed coun-
tries, leaving the incidence rate of gastric cancer much
higher in Asia than in Western and developing countries
[12]. The temporal pattern of UGI cancer incidence
trends in Western countries is that of decreasing inci-
dence of gastric cancer and a shift in cancer site from
the distal to the proximal stomach [13, 14]. This has
been noted worldwide in diverse populations [14, 15].
We have no precise information on the epidemiology of
UGI cancer in northeastern Turkey, or in Turkey over-
all. However, many studies have indicated that upper
UGI cancers are endemic in Erzurum and its surround-
ings, and several studies have attempted to uncover the
underlying reasons for this [6–9, 16].
Worldwide, algorithms and standard treatment methods
are applied to the early diagnosis of gastric cancer. How-
ever, the frequency, age group, histology, and anatomic
sites of gastric cancer are known to have different charac-
teristics in different geographic regions. This feature
prompted the present study, which evaluated the results
of UGI endoscopies performed in two tertiary hospi-
tals in Erzurum, in northeastern Turkey, to investigate
whether the universal use of current gastric cancer
Fig. 1 Erzurum is a province of Turkey in the Northeastern Anatolia Region of the country. It is bordered by the provinces of Kars and Ağrı to the
east, Muş and Bingöl to the south, Erzincan and Bayburt to the west, Rize and Artvin to the north, and Ardahan to the northeast. These provinces
are shown on the Europe map (taken from https://commons.wikimedia.org/wiki/T%C3%BCrkiye#/media/File:Europe_location_Turkey.svg and has
been changed by authors).
Table 4 Distribution of the metastasis sites among esophageal
and gastric cancer patients (n = 659) at presentation




Total (n / %)
Lymph nodes 148 / 22.5 % 219 / 33.2 % 367 / 56.1 %
Liver 49 / 7.4 % 153 / 23.2 % 202 / 30.7 %
Peritonitis
carsinamotosa
13 / 2.0 % 138 / 20.9 % 151 / 22.9 %
Lung 31 / 4.7 % 47 / 7.1 % 78 / 11.8 %
Neck 29 / 4.4 % 3 / 0.5 % 32 / 4.8 %
Other 7 / 1.1 % 29 / 4.4 % 36 / 5.4 %
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scanning and treatment methods should be re-
evaluated based on these results.
Age-standardized incidence rates of gastric cancer are
about twice as high in Eastern Asian men as in Eastern
Asian women, at 35.4 per 100,000 in males and 13.8 per
100,000 in females [17]. In 2009, the age-standard cancer
speed in Turkey was 269.7 per 100,000 in men, and 173.3
per 100,000 in women. The woman-man average cancer
incidence is 221.5 per 100,000. In 2009, the age-standard
gastric and esophageal cancer speeds in Turkey were 16.2
and 2.6, respectively, per 100,000 in men and 8.1 and 1.3,
respectively, per 100,000 in women [18]. In the 25–49
years age group, gastric cancer accounts for 6.7 % of the
cancers in Turkey in men and 3.2 % in women [11].
The frequency of stomach cancer varies from region
to region in Turkey. A study conducted in southeastern
Turkey reported a frequency of esophageal cancer of
0.4 %, and a stomach cancer frequency of 2.1 % in
patients who had undergone endoscopy [19]. A similar
study reported a frequency of esophageal cancer of 0.3 %
and a frequency of stomach cancer of 2.0 % in midwestern
Turkey [20]. A study conducted in central Turkey re-
ported an endoscopic frequency of stomach cancer of
4.0 % [21]. A study conducted in northwestern Turkey
reported the frequency of esophageal cancer as 0.3 % and
the frequency of stomach cancer as 1.8 % [22].
Likewise, the frequency of upper UGI cancers in
Turkey varies from region to region. The present study
detected 1,007 cancer cases from the 25,037 UGI system
endoscopies conducted in the region of the study; 719 of
these cases were settled in the gastric region, and 276
were settled in the esophageal region.
Patients were under age 45 in 9.8 % of the gastric can-
cer cases and in 5.4 % of the esophageal cancer cases.
When assessed based on age groups, the gastric cancer
rate in patients under 45 in the present study was much
higher than the gastric cancer rate in the same age group
in Turkey overall. That is to say, gastric cancer occurs at a
much higher rate and at a younger age in the eastern and
northeastern regions of Turkey than in the other regions
of the country. These regional differences may reflect vari-
able regional distributions of environmental or life-style
risk factors. Therefore, we suggest that upper UGI endos-
copies be recommended for those 45 and older and that
further research be conducted into the gastric cancer rates
in the eastern and northeastern regions of Turkey.
H. pylori infection is a main factor leading to atrophy,
intestinal metaplasia, and cancer development in the
stomach [23]. In the present study, 512 patients with
gastric cancer had been checked for the presence of H.
pylori. We observed that 71.2 % of them were positive
for H. pylori. Similarly, in those studies conducted in the
same region as the present study, the frequency of H.
pylori was reported as 71.5–78 % [24, 25].
Proximal gastric cancer has a worse prognosis than
distal gastric cancer because it is deeply invasive, it has a
high incidence of lymph node metastasis, and its unclear
symptoms result in delayed diagnosis [26]. Unfortu-
nately, the global incidence of proximal gastric cancers
has increased compared to distal cancers [12]. The
present study, in parallel with the literature, confirmed
that proximal gastric cancers occurred at a much higher
rate than distal cancers.
In the present study, most of the gastric and esopha-
geal cancer cases were from the cities of Erzurum, Agri,
and Kars [27]. In contrast, Turkdogan et al. reported
that gastric cancer was endemic in Van and its sur-
roundings [9]. The reason the present study found few
cancers in Van and its surroundings is because very few
patients from the Van region had undergone endoscopy
at the 2 hospitals involved in the present study.
In the region where the present study was conducted,
proximal gastric cancers occurred at a much higher rate,
as reported previously. However, in contrast to the
present study, a multicenter retrospective study of gas-
tric cancers in Turkey found a much higher rate of distal
gastric cancers [18]. In other words, gastric cancers do
not have the same characteristics in every region of
Turkey. The lymphatic drainage and blood buildup differ
between proximal and distal gastric cancers; therefore,
we believe each geographical region requires new scan-
ning, treatment, and follow-up modalities that are
specific to that region [26].
A study involving 796 patients in Istanbul, Turkey
reported that 61.9 % of those with gastric cancer had
adenocarcinoma (intestinal type) and 31.9 % had signet
ring cell (diffused) [28]. In addition, a study by Tural
et al. and other studies have reported similar rates [29, 30].
Nevertheless, in the present study, 87.6 % of the patients
had adenocarcinoma (intestinal type) and 4.9 % had signet
ring cell (diffused) cancer. Different characteristics,
such as the settlement of the tumor, are seen in differ-
ent histological types. This supports our recommendation
that treatment and follow-up of various histological types
should be specific to each type.
In the present study, lymph nodes were the most
frequent site of metastasis. In addition, the study de-
termined that other metastases occurred at a rate si-
milar to those reported in the literature. Remote
metastases were reported at lower rates in the litera-
ture [31, 32]. However, metastatic cancer rates were
higher in the present study. We believe that the most
probable reason for this is that the present study
researched upper UGI cancers in patients who had
underdone endoscopy. Furthermore, for reasons that
are not yet known, the cancers in the region of the
present study occurred at younger ages and progressed
more aggressively.
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Conclusions
We determined that upper UGI cancer patients are
observed more frequently in northeastern Turkey than
in its western regions, Europe, or the USA. In addition,
patients with much higher rates of upper UGI cancer
were younger than 45 years. Therefore, we believe that
alarm symptoms and endoscopic scanning programs
require new, region-specific criteria to diagnose upper
UGI cancers in this northeastern Turkey. It is necessary
to develop scanning, follow-up, and treatment strategies
specific to those patient groups who exhibit these differ-
ent characteristics, and these strategies must take into
consideration differences in the histopathology of the
tumors, their localization, and the ages of the patients.
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